I hope Eath comes back on to explain to you all the significance of the trial.
It's all to do about
1/where this trial sits in the overall development of a potential vaccine and
2/ the statistical significance of the results (it's power was small because of the small number of participants) .. but that has to do with point 1/)
and
3/ the costs of taking it further.
Listen to what he says about it OK?
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$8.19

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-147
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.19 |
Change
0.000(0.00%) |
Mkt cap ! $117.7M |
Open | High | Low | Value | Volume |
$8.19 | $8.19 | $8.19 | $991 | 121 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3671 | $7.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.10 | 583 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3671 | 7.680 |
1 | 230 | 7.670 |
1 | 231 | 7.650 |
1 | 2000 | 7.520 |
1 | 400 | 7.500 |
Price($) | Vol. | No. |
---|---|---|
8.100 | 583 | 2 |
8.190 | 93 | 2 |
8.340 | 167 | 2 |
8.400 | 5632 | 2 |
8.490 | 1368 | 1 |
Last trade - 09.59am 18/09/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |